Oragenics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.84 million compared to USD 4.59 million a year ago. Basic loss per share from continuing operations was USD 1.41 compared to USD 2.29 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +1.90% | +3.88% | -80.98% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Mar. 29 | Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-80.98% | 4.79M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- OGEN Stock
- News Oragenics, Inc.
- Oragenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023